Press Releases GeNeuro SA

Equities

GNRO

CH0308403085

Biotechnology & Medical Research

Market Closed - Euronext Paris Other stock markets 11:55:00 2026-01-23 am EST			5-day change	1st Jan Change
0.0308 ^EUR	0.00%		-4.35%	-1.91%

08:28am	GeNeuro Requests Trading Halt on Euronext Paris Pending Debt Moratorium Ruling	MT
05:28am	GeNeuro Suspends Trading in Paris

Press Releases

07:17am	GeNeuro : Inside Information / Other news releases	PU
05:00am	GeNeuro SA Requests Temporary Suspension of Trading of Its Shares on Euronext Paris	BU
25-10-20	GeNeuro : annonce le report de la publication de son rapport semestriel au 30 juin 2025	PU
25-10-15	GeNeuro SA Postpones Publication of June 30, 2025 Half-Yearly Financial Report	BU
25-09-26	GeNeuro SA Announces the Extension of its Definitive Debt-Restructuring Moratorium	BU
25-07-16	GeNeuro SA Announces the Liquidation of Its French Subsidiary GeNeuro Innovation SAS	BU
25-06-30	GeNeuro Announces Approval of All Resolutions Proposed at Extraordinary General Meeting	BU
25-06-12	GeNeuro : Inside Information / Other news releases	PU
25-06-12	GeNeuro SA Announces the Opening of Receivership Proceedings for Its French Subsidiary GeNeuro Innovation SAS	BU
25-06-10	GeNeuro SA Announces an Extraordinary Shareholders’ Meeting on June 30, 2025	BU
25-05-27	GeNeuro SA Announces Definitive Debt-Restructuring Moratorium	BU
25-05-12	GeNeuro SA Announces the Postponement of the Publication of the Company's 2024 Annual Results	BU
25-01-28	GeNeuro SA Announces Renewal of Provisional Debt-Restructuring Moratorium	BU
24-12-06	New Data Supporting a New Precision Medicine Approach for ALS Patients With GeNeuro’s GNK-301 Presented at the 35th International Symposium on ALS/MND	BU
24-09-30	GeNeuro SA Obtains the Opening of Debt-Restructuring Proceedings	BU
24-09-19	GeNeuro: New Data Presented at the ECTRIMS 2025 Congress in Copenhagen Shows That Temelimab Rescues the Neurodegenerative Effects of HERV-W in an MS Model	BU
24-07-15	GeNeuro Announces That It Submits a Request for a Debt Moratorium to the Geneva Court of First Instance	BU
24-07-10	GeNeuro : Fin du contrat de liquidité conclu avec GILBERT DUPONT	PU
24-07-10	GeNeuro SA: End of the Liquidity Contract With GILBERT DUPONT	BU
24-07-03	Geneuro SA: Half-Yearly Report on the Liquidity Contract with Gilbert Dupont	BU
24-06-28	GeNeuro : Inside Information / Other news releases	PU
24-06-28	GeNeuro : Announces Results of the GNC 501 Study in Post Covid 19 Syndrome	PU
24-06-28	GeNeuro Announces Results of the GNC-501 Study in Post-Covid-19 Syndrome	BU
24-06-14	GeNeuro Announces Approval of all Resolutions Proposed at 2024 Annual General Meeting	BU
24-05-29	Availability of documents and information for the annual shareholders’ meeting of June 12, 2024	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies Trading Ideas

Press Releases GeNeuro SA

Equities

GNRO

CH0308403085

Biotechnology & Medical Research

Press Releases

Filters